Advanced Proteome Therapeutics Corp (APC)-Financial and Strategic SWOT Analysis Review

Advanced Proteome Therapeutics Corp (APC)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH57124FSA
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Advanced Proteome Therapeutics Corp (APC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp Key Recent Developments

Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team

Jan 17, 2017: Advanced Proteome Therapeutics Announces Issuance of U.S. Patent Covering Novel Molecules for the Treatment of Cancer

Nov 29, 2016: APC Invents Quantitative Method for Assessing Pattern of Antibody Labeling Impacting the Emerging, Rapidly Growing Market for Antibody-Drug Conjugates (ADC)

Jul 18, 2016: Advanced Proteome Therapeutics Formulates Strategic Plan Featuring Novel Antibody Program

Jun 14, 2016: Advanced Proteome Therapeutics and Heidelberg Pharma collaborate to create improved cancer therapeutics

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Advanced Proteome Therapeutics Corp-Key Facts 6

Advanced Proteome Therapeutics Corp-Key Employees 7

Advanced Proteome Therapeutics Corp-Key Employee Biographies 8

Advanced Proteome Therapeutics Corp-Major Products and Services 9

Advanced Proteome Therapeutics Corp-Pharmaceutical Pipeline Products Data 10

Advanced Proteome Therapeutics Corp, Pipeline Products by Therapy Area 10

Advanced Proteome Therapeutics Corp, Pipeline Products by Development Phase 11

Advanced Proteome Therapeutics Corp-History 12

Advanced Proteome Therapeutics Corp-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Advanced Proteome Therapeutics Corp-Business Description 15

Advanced Proteome Therapeutics Corp-SWOT Analysis 16

SWOT Analysis-Overview 16

Advanced Proteome Therapeutics Corp-Strengths 16

Advanced Proteome Therapeutics Corp-Weaknesses 17

Advanced Proteome Therapeutics Corp-Opportunities 18

Advanced Proteome Therapeutics Corp-Threats 19

Advanced Proteome Therapeutics Corp-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Advanced Proteome Therapeutics Corp, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 30

Jan 17, 2017: Advanced Proteome Therapeutics Announces Issuance of U.S. Patent Covering Novel Molecules for the Treatment of Cancer 31

Nov 29, 2016: APC Invents Quantitative Method for Assessing Pattern of Antibody Labeling Impacting the Emerging, Rapidly Growing Market for Antibody-Drug Conjugates (ADC) 32

Jul 18, 2016: Advanced Proteome Therapeutics Formulates Strategic Plan Featuring Novel Antibody Program 33

Jun 14, 2016: Advanced Proteome Therapeutics and Heidelberg Pharma collaborate to create improved cancer therapeutics 34

Apr 15, 2016: Advanced Proteome Therapeutics Embarks Upon a Major Antibody Initiative 35

Mar 24, 2016: Advanced Proteome Therapeutics to Attend BIO-Europe Spring 2016 Partnering Conference 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Advanced Proteome Therapeutics Corp, Pipeline Products by Therapy Area 10

Advanced Proteome Therapeutics Corp, Pipeline Products by Development Phase 11

Advanced Proteome Therapeutics Corp, Performance Chart (2012-2016) 24

Advanced Proteome Therapeutics Corp, Ratio Charts 26

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

List of Tables

Advanced Proteome Therapeutics Corp, Key Facts 6

Advanced Proteome Therapeutics Corp, Key Employees 7

Advanced Proteome Therapeutics Corp, Key Employee Biographies 8

Advanced Proteome Therapeutics Corp, Major Products and Services 9

Advanced Proteome Therapeutics Corp, Number of Pipeline Products by Therapy Area 10

Advanced Proteome Therapeutics Corp, Number of Pipeline Products by Development Stage 11

Advanced Proteome Therapeutics Corp, History 12

Advanced Proteome Therapeutics Corp, Subsidiaries 14

Advanced Proteome Therapeutics Corp, Key Competitors 20

Advanced Proteome Therapeutics Corp, Ratios based on current share price 21

Advanced Proteome Therapeutics Corp, Annual Ratios 22

Advanced Proteome Therapeutics Corp (Cont...1), Annual Ratios 23

Advanced Proteome Therapeutics Corp, Interim Ratios 25

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Advanced Proteome Therapeutics Corp, Recent Deals Summary 29

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 39

Efficiency Ratios 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

ZIOPHARM Oncology Inc, Surface Oncology Inc, Oncorus Inc, Oncolinx LLC, Neon Therapeutics Inc, Aileron Therapeutics Inc

Advanced Proteome Therapeutics Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8118
Site License
USD 250 INR 16235
Corporate User License
USD 375 INR 24353

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com